 | • レポートコード：MRC2Q12-19345 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、プレロムチリンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 プレロムチリンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 プレロムチリンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 プレロムチリンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのプレロムチリンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のプレロムチリンの売上および2028年までの予測に焦点を当てています。 プレロムチリンのグローバル主要企業には、Shanxi Xinyuan Huakang、Hubei Chenxin Pharmaceutical、Nabriva、Pfizer、Weikeqi Biotech、JZEG、Tairui、Guandu Hebei、Shandong Shengli、Bayer、Elanco、MSD、Cahic、Ringpu、Baolingなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 プレロムチリン市場は、タイプとアプリケーションによって区分されます。世界のプレロムチリン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 チアムリン、レタパムリン、バルネムリン、レファムリン、その他 【アプリケーション別セグメント】 医学、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - プレロムチリン製品概要 - タイプ別市場（チアムリン、レタパムリン、バルネムリン、レファムリン、その他） - アプリケーション別市場（医学、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界のプレロムチリン販売量予測2017-2028 - 世界のプレロムチリン売上予測2017-2028 - プレロムチリンの地域別販売量 - プレロムチリンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別プレロムチリン販売量 - 主要メーカー別プレロムチリン売上 - 主要メーカー別プレロムチリン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（チアムリン、レタパムリン、バルネムリン、レファムリン、その他） - プレロムチリンのタイプ別販売量 - プレロムチリンのタイプ別売上 - プレロムチリンのタイプ別価格 ・アプリケーション別市場規模（医学、科学研究） - プレロムチリンのアプリケーション別販売量 - プレロムチリンのアプリケーション別売上 - プレロムチリンのアプリケーション別価格 ・北米市場 - 北米のプレロムチリン市場規模（タイプ別、アプリケーション別） - 主要国別のプレロムチリン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのプレロムチリン市場規模（タイプ別、アプリケーション別） - 主要国別のプレロムチリン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のプレロムチリン市場規模（タイプ別、アプリケーション別） - 主要国別のプレロムチリン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のプレロムチリン市場規模（タイプ別、アプリケーション別） - 主要国別のプレロムチリン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのプレロムチリン市場規模（タイプ別、アプリケーション別） - 主要国別のプレロムチリン市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi Xinyuan Huakang、Hubei Chenxin Pharmaceutical、Nabriva、Pfizer、Weikeqi Biotech、JZEG、Tairui、Guandu Hebei、Shandong Shengli、Bayer、Elanco、MSD、Cahic、Ringpu、Baoling ・産業チェーン及び販売チャネル分析 - プレロムチリンの産業チェーン分析 - プレロムチリンの原材料 - プレロムチリンの生産プロセス - プレロムチリンの販売及びマーケティング - プレロムチリンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - プレロムチリンの産業動向 - プレロムチリンのマーケットドライバー - プレロムチリンの課題 - プレロムチリンの阻害要因 ・主な調査結果 |
Pleuromutilin and its derivatives are antibacterial drugs that inhibit protein synthesis in bacteria by binding to the peptidyl transferase component of the 50S subunit of ribosomes.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Pleuromutilin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Pleuromutilin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Pleuromutilin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Pleuromutilin include Shanxi Xinyuan Huakang, Hubei Chenxin Pharmaceutical, Nabriva, Pfizer, Weikeqi Biotech, JZEG, Tairui, Guandu Hebei and Shandong Shengli, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pleuromutilin manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Pleuromutilin market. Further, it explains the major drivers and regional dynamics of the global Pleuromutilin market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Shanxi Xinyuan Huakang
Hubei Chenxin Pharmaceutical
Nabriva
Pfizer
Weikeqi Biotech
JZEG
Tairui
Guandu Hebei
Shandong Shengli
Bayer
Elanco
MSD
Cahic
Ringpu
Baoling
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by kinds and by application segments based on sales, price, and value for the period 2017-2028.
Pleuromutilin Segment by Kinds
Tiamulin
Retapamulin
Valnemulin
Lefamulin
Other
Pleuromutilin Segment by Application
Medicine
Scientific Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pleuromutilin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Pleuromutilin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Pleuromutilin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pleuromutilin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pleuromutilin sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pleuromutilin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pleuromutilin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Shanxi Xinyuan Huakang, Hubei Chenxin Pharmaceutical, Nabriva, Pfizer, Weikeqi Biotech, JZEG, Tairui, Guandu Hebei and Shandong Shengli, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pleuromutilin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pleuromutilin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by kinds, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by kinds, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by kinds, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by kinds, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by kinds, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pleuromutilin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Pleuromutilin Product Introduction
1.2 Market by Kinds
1.2.1 Global Pleuromutilin Market Size Growth Rate by Kinds, 2017 VS 2021 VS 2028
1.2.2 Tiamulin
1.2.3 Retapamulin
1.2.4 Valnemulin
1.2.5 Lefamulin
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pleuromutilin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pleuromutilin Sales Estimates and Forecasts 2017-2028
2.2 Global Pleuromutilin Revenue Estimates and Forecasts 2017-2028
2.3 Global Pleuromutilin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pleuromutilin Sales by Region
2.4.1 Global Pleuromutilin Sales by Region (2017-2022)
2.4.2 Global Sales Pleuromutilin by Region (2023-2028)
2.5 Global Pleuromutilin Revenue by Region
2.5.1 Global Pleuromutilin Revenue by Region (2017-2022)
2.5.2 Global Pleuromutilin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pleuromutilin Sales by Manufacturers
3.1.1 Global Top Pleuromutilin Manufacturers by Sales (2017-2022)
3.1.2 Global Pleuromutilin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pleuromutilin in 2021
3.2 Global Pleuromutilin Revenue by Manufacturers
3.2.1 Global Pleuromutilin Revenue by Manufacturers (2017-2022)
3.2.2 Global Pleuromutilin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pleuromutilin Revenue in 2021
3.3 Global Pleuromutilin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pleuromutilin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pleuromutilin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Kinds
4.1 Global Pleuromutilin Sales by Kinds
4.1.1 Global Pleuromutilin Historical Sales by Kinds (2017-2022)
4.1.2 Global Pleuromutilin Forecasted Sales by Kinds (2023-2028)
4.1.3 Global Pleuromutilin Sales Market Share by Kinds (2017-2028)
4.2 Global Pleuromutilin Revenue by Kinds
4.2.1 Global Pleuromutilin Historical Revenue by Kinds (2017-2022)
4.2.2 Global Pleuromutilin Forecasted Revenue by Kinds (2023-2028)
4.2.3 Global Pleuromutilin Revenue Market Share by Kinds (2017-2028)
4.3 Global Pleuromutilin Price by Kinds
4.3.1 Global Pleuromutilin Price by Kinds (2017-2022)
4.3.2 Global Pleuromutilin Price Forecast by Kinds (2023-2028)
5 Market Size by Application
5.1 Global Pleuromutilin Sales by Application
5.1.1 Global Pleuromutilin Historical Sales by Application (2017-2022)
5.1.2 Global Pleuromutilin Forecasted Sales by Application (2023-2028)
5.1.3 Global Pleuromutilin Sales Market Share by Application (2017-2028)
5.2 Global Pleuromutilin Revenue by Application
5.2.1 Global Pleuromutilin Historical Revenue by Application (2017-2022)
5.2.2 Global Pleuromutilin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pleuromutilin Revenue Market Share by Application (2017-2028)
5.3 Global Pleuromutilin Price by Application
5.3.1 Global Pleuromutilin Price by Application (2017-2022)
5.3.2 Global Pleuromutilin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pleuromutilin Market Size by Kinds
6.1.1 North America Pleuromutilin Sales by Kinds (2017-2028)
6.1.2 North America Pleuromutilin Revenue by Kinds (2017-2028)
6.2 North America Pleuromutilin Market Size by Application
6.2.1 North America Pleuromutilin Sales by Application (2017-2028)
6.2.2 North America Pleuromutilin Revenue by Application (2017-2028)
6.3 North America Pleuromutilin Market Size by Country
6.3.1 North America Pleuromutilin Sales by Country (2017-2028)
6.3.2 North America Pleuromutilin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pleuromutilin Market Size by Kinds
7.1.1 Europe Pleuromutilin Sales by Kinds (2017-2028)
7.1.2 Europe Pleuromutilin Revenue by Kinds (2017-2028)
7.2 Europe Pleuromutilin Market Size by Application
7.2.1 Europe Pleuromutilin Sales by Application (2017-2028)
7.2.2 Europe Pleuromutilin Revenue by Application (2017-2028)
7.3 Europe Pleuromutilin Market Size by Country
7.3.1 Europe Pleuromutilin Sales by Country (2017-2028)
7.3.2 Europe Pleuromutilin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pleuromutilin Market Size by Kinds
8.1.1 Asia Pacific Pleuromutilin Sales by Kinds (2017-2028)
8.1.2 Asia Pacific Pleuromutilin Revenue by Kinds (2017-2028)
8.2 Asia Pacific Pleuromutilin Market Size by Application
8.2.1 Asia Pacific Pleuromutilin Sales by Application (2017-2028)
8.2.2 Asia Pacific Pleuromutilin Revenue by Application (2017-2028)
8.3 Asia Pacific Pleuromutilin Market Size by Region
8.3.1 Asia Pacific Pleuromutilin Sales by Region (2017-2028)
8.3.2 Asia Pacific Pleuromutilin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pleuromutilin Market Size by Kinds
9.1.1 Latin America Pleuromutilin Sales by Kinds (2017-2028)
9.1.2 Latin America Pleuromutilin Revenue by Kinds (2017-2028)
9.2 Latin America Pleuromutilin Market Size by Application
9.2.1 Latin America Pleuromutilin Sales by Application (2017-2028)
9.2.2 Latin America Pleuromutilin Revenue by Application (2017-2028)
9.3 Latin America Pleuromutilin Market Size by Country
9.3.1 Latin America Pleuromutilin Sales by Country (2017-2028)
9.3.2 Latin America Pleuromutilin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pleuromutilin Market Size by Kinds
10.1.1 Middle East and Africa Pleuromutilin Sales by Kinds (2017-2028)
10.1.2 Middle East and Africa Pleuromutilin Revenue by Kinds (2017-2028)
10.2 Middle East and Africa Pleuromutilin Market Size by Application
10.2.1 Middle East and Africa Pleuromutilin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pleuromutilin Revenue by Application (2017-2028)
10.3 Middle East and Africa Pleuromutilin Market Size by Country
10.3.1 Middle East and Africa Pleuromutilin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pleuromutilin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi Xinyuan Huakang
11.1.1 Shanxi Xinyuan Huakang Corporation Information
11.1.2 Shanxi Xinyuan Huakang Overview
11.1.3 Shanxi Xinyuan Huakang Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi Xinyuan Huakang Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi Xinyuan Huakang Recent Developments
11.2 Hubei Chenxin Pharmaceutical
11.2.1 Hubei Chenxin Pharmaceutical Corporation Information
11.2.2 Hubei Chenxin Pharmaceutical Overview
11.2.3 Hubei Chenxin Pharmaceutical Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hubei Chenxin Pharmaceutical Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hubei Chenxin Pharmaceutical Recent Developments
11.3 Nabriva
11.3.1 Nabriva Corporation Information
11.3.2 Nabriva Overview
11.3.3 Nabriva Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nabriva Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nabriva Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Weikeqi Biotech
11.5.1 Weikeqi Biotech Corporation Information
11.5.2 Weikeqi Biotech Overview
11.5.3 Weikeqi Biotech Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Weikeqi Biotech Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Weikeqi Biotech Recent Developments
11.6 JZEG
11.6.1 JZEG Corporation Information
11.6.2 JZEG Overview
11.6.3 JZEG Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 JZEG Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JZEG Recent Developments
11.7 Tairui
11.7.1 Tairui Corporation Information
11.7.2 Tairui Overview
11.7.3 Tairui Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Tairui Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tairui Recent Developments
11.8 Guandu Hebei
11.8.1 Guandu Hebei Corporation Information
11.8.2 Guandu Hebei Overview
11.8.3 Guandu Hebei Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Guandu Hebei Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Guandu Hebei Recent Developments
11.9 Shandong Shengli
11.9.1 Shandong Shengli Corporation Information
11.9.2 Shandong Shengli Overview
11.9.3 Shandong Shengli Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shandong Shengli Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shandong Shengli Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Overview
11.10.3 Bayer Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Recent Developments
11.11 Elanco
11.11.1 Elanco Corporation Information
11.11.2 Elanco Overview
11.11.3 Elanco Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Elanco Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Elanco Recent Developments
11.12 MSD
11.12.1 MSD Corporation Information
11.12.2 MSD Overview
11.12.3 MSD Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 MSD Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 MSD Recent Developments
11.13 Cahic
11.13.1 Cahic Corporation Information
11.13.2 Cahic Overview
11.13.3 Cahic Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Cahic Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cahic Recent Developments
11.14 Ringpu
11.14.1 Ringpu Corporation Information
11.14.2 Ringpu Overview
11.14.3 Ringpu Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ringpu Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ringpu Recent Developments
11.15 Baoling
11.15.1 Baoling Corporation Information
11.15.2 Baoling Overview
11.15.3 Baoling Pleuromutilin Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Baoling Pleuromutilin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Baoling Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pleuromutilin Industry Chain Analysis
12.2 Pleuromutilin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pleuromutilin Production Mode & Process
12.4 Pleuromutilin Sales and Marketing
12.4.1 Pleuromutilin Sales Channels
12.4.2 Pleuromutilin Distributors
12.5 Pleuromutilin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pleuromutilin Industry Trends
13.2 Pleuromutilin Market Drivers
13.3 Pleuromutilin Market Challenges
13.4 Pleuromutilin Market Restraints
14 Key Findings in The Global Pleuromutilin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer